Developing personalised medicine approaches to cancer|Steven Yatomi-Clarke,CEO,Prescient Therapeutics Ltd 00:10:00

Share On Facebook Share On Twitter

Steven took over as CEO of Prescient Therapeutics in 2016 and has overseen its progression from start-up phase. Steven manages a team in Australia and the US and has been instrumental in strategy development; licensing; initiating and managing clinical trials; fundraising and business development.

Recent Videos